Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- University of Arizona
- Study ID
- NCT06975306
- Status
- Recruiting
Conditions
- ACL Injuries
- Bone Graft; Complications
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 40 Years
- Healthy Volunteers
- Not accepted
Interventions
- autologous bone grafts — PROCEDUREgroup will be treated with autologous bone graft for BTB ACLR
- Demineralized bone matrix (DBM) — OTHERDemineralized bone matrix (DBM) is a biologic allograft product derived from bone tissue that has undergone a process of demineralization to remove inorganic mineral components while retaining the organic matrix, including proteins and growth factors.
Study Details
All patients will be randomly assigned using a computer randomization algorithm to one of two matched cohort groups. Patients will not be advised which group they belong to until after the completion of the study. One group will be treated with autologous bone graft for bone patellar-tendon bone (BTB) Anterior Cruciate Ligament Reconstruction (ACLR), and the other group will be treated with commercially available DBM (Demineralized bone matrix) putty. Patients will be enrolled from Banner University. Before and after surgery, patient reported outcomes including visual analog pain scale (VAS), Tegner-Lysholm and Cincinnati ACL Test. The principal investigator will evaluate the patients on subjective criteria such as pain and objective criteria including range of motion, arthritic changes seen on radiographs, infection, and ability to kneel.
Key Dates
- Start date
- Feb 11, 2025
- Status verified
- May 2025
- Primary completion
- May 31, 2026
- Completion
- May 31, 2026
Study Design
- Enrollment
- 75 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: autologous bone graftOne group will be treated with autologous bone graft for BTB ACLR
- Experimental: Demineralized bone matrix (DBM) puttyDemineralized bone matrix (DBM) is a biologic allograft product derived from bone tissue that has undergone a process of demineralization to remove inorganic mineral components while retaining the organic matrix, including proteins and growth factors.
Primary Outcome Measure
change in surgical time [ Time Frame: Duration of Procedure ]
Central Contacts
- Marleny Munoz602-793-9582
- Phoenix Biomedical Campus Regulatory Team
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Banner Health Center Plus - Arcadia | Phoenix | Arizona | 85008 | |
| Banner University Medical Center Phoenix | Phoenix | Arizona | 85006 | |
| Banner Sports Medicine Scottsdale | Scottsdale | Arizona | 85256 |
Find similar trials in Phoenix, AZ
Related Studies
- Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave TherapyRecruiting · Spaulding Rehabilitation Hospital · Cambridge, Massachusetts
- Non-Narcotic Pain Control After ACL ReconstructionPHASE3 · Recruiting · The Cleveland Clinic · Coral Springs, Florida
- Menstrual Cycle-Synced Neuromuscular TrainingEnrolling By Invitation · Sophia Ulman · Frisco, Texas